No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
200 |
4. Check minimum number of eventsNone |
200 |
5. Include endpointsNone |
200 |
6. Filter based on genotype QC (FinnGen only) |
200 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
- Parent code in ICD-10
- E22
- Name in latin
- Hyperprolactinaemia
Similar endpoints
↥List of similar endpoints to
Hyperprolactinaemia, drug-induced
based on the number of shared cases.
Similar with more cases:
- Hyperprolactinaemia
- Hyperfunction of pituitary gland
- Exclusions for E4_PCOS_BROAD
- Disorders of other endocrine glands
- Exclusions for E4_PCOS_CONSORTIUM
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 200 | 173 | 27 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.01 |
| Median age at first event (years) | 38.59 | 36.44 | 52.33 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 187
- Matched controls
- 1870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E22.1
ICD-10 Finland
Hyperprolactinaemia
+∞
257.0
187
8
G02CB01
ATC
bromocriptine; systemic
249.2
144.3
135
19
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
183.4
53.0
53
*
G02CB03
ATC
cabergoline; oral (prolactine inhibitors)
617.2
49.8
47
*
N04BC06
ATC
cabergoline; oral (dopamine agonists)
371.7
31.9
31
*
G02CB04
ATC
quinagolide; oral
371.7
31.9
31
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
91.4
22.2
24
*
XLA10
NOMESCO Finland
NA
7.2
19.6
51
92
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
+∞
14.8
14
*
G03DB01
ATC
dydrogesterone; oral
3.8
13.2
65
228
2531A
ICD-9 Finland
Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]
+∞
11.6
11
*
E23.00
ICD-10 Finland
Panhypopituitarism
105.1
9.5
10
*
101
Kela drug reimbursment
Anterior pituitary hypofunction
38.7
9.1
11
*
H02AB09
ATC
hydrocortisone; systemic
8.9
8.8
18
22
N91.1
ICD-10 Finland
Secondary amenorrhoea
19.4
7.7
11
6
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
+∞
7.3
7
*
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
+∞
7.3
7
*
N05AA01
ATC
chlorpromazine; systemic, rectal
9.9
6.9
13
14
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.0
6.7
26
72
N05AX08
ATC
risperidone; systemic
4.6
6.6
22
53
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.2
6.3
82
482
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
+∞
6.3
6
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
8.1
6.2
13
17
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
18
15
13.09
18.05
5.6
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
78
496
1.94
4.72
5.1
3.6
ph
7.4
7.4
—
10
90
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
51
294
1.99
4.02
3.0
2.6
mmol/l
2.5
2.4
0.61
43
265
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
6
5
12.31
3.78
1.5
2.2
ug/l
1.4
1.9
—
6
5
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
8
12
6.89
3.71
3.9
16.8
nmol/l
819.4
1142.3
—
8
12
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
8
12
6.89
3.71
8.1
18.1
nmol/l
1723.3
2136.5
—
8
12
(3019060) Gas panel - Arterial blood
19
80
2.52
3.17
4.8
4.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
86
628
1.65
2.96
2.3
1.9
pmol/l
89.4
99.0
0.98
39
306
(3001122) Ferritin [Mass/volume] in Serum or Plasma
102
787
1.60
2.75
3.3
2.7
ug/l
90.2
89.0
0.03
97
735
(3035637) Corticotropin [Mass/volume] in Plasma
8
19
4.34
2.70
1.0
1.5
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
15
4.79
2.62
4.9
2.5
nmol/l
5.7
2.7
—
7
15
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
62
2.53
2.61
4.1
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
145
2.00
2.57
1.3
1.3
iu/l
18.1
29.3
1.72
22
127
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
41
255
1.76
2.50
3.1
2.4
e6/l
0.5
1.1
1.25
24
135
(3026008) Bacteria identified in Urine by Culture
67
478
1.60
2.45
4.2
2.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
12
5.12
2.42
2.2
4.5
—
—
—
0
0
(3003338) MCHC [Mass/volume]
169
1503
1.80
2.38
25.3
15.6
g/l
330.5
331.4
0.64
169
1498
(3013707) Erythrocyte sedimentation rate by Westergren method
152
1316
1.65
2.35
4.2
4.0
mm/h
12.9
10.6
1.25
146
1222
(3016018) Differential panel - Cerebral spinal fluid
6
13
4.72
2.29
1.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
29
3.20
2.25
1.3
1.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
40
256
1.70
2.21
1.7
1.7
nmol/l
1152.5
1212.6
0.16
32
196
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
24
3.43
2.20
1.0
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
19
95
2.10
2.19
3.3
2.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
95
749
1.51
2.17
8.4
8.4
e9/l
0.0
0.0
0.63
76
604
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
155
1.86
2.13
2.0
1.8
—
—
—
0
0
(3019225) pH of Specimen
5
144
0.33
2.12
2.0
4.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
27
158
1.82
2.01
2.1
1.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
111
914
1.48
2.00
5.8
3.7
mmol/l
6.5
6.5
0.20
103
858
(40758558) Short blood count panel - Blood
60
438
1.53
1.93
8.9
7.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
52
368
1.56
1.92
1.7
1.5
nmol/l
18.5
21.3
0.84
46
311
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
36
233
1.66
1.91
3.3
2.6
e6/l
5.5
3.1
0.40
20
113
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
35
225
1.67
1.90
2.0
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
21
117
1.89
1.82
2.5
3.5
mmol/l
2.6
2.1
0.29
16
96
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
98
798
1.45
1.81
8.6
5.8
mmol/l
1.2
1.2
0.25
89
681
(3035350) Ketones [Presence] in Urine by Test strip
100
818
1.44
1.80
4.1
3.3
estimate
0.0
0.0
0.00
18
152
(3021601) Nitrite [Presence] in Urine by Test strip
100
820
1.44
1.77
5.7
4.6
estimate
0.1
0.0
0.79
19
157
(3023410) Appearance of Cerebral spinal fluid
6
18
3.40
1.76
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
75
2.08
1.74
1.2
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
100
824
1.43
1.70
4.2
3.4
estimate
0.0
0.0
0.00
17
151
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
17
93
1.90
1.57
1.3
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
271
1.55
1.56
4.2
3.2
ng/l
38.0
140.3
1.40
26
187
(3012544) pH of Venous blood
21
124
1.77
1.54
2.3
3.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
70
550
1.42
1.52
3.3
2.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
35
239
1.56
1.51
1.7
1.6
—
—
—
0
0
(3013512) EKG study
31
447
0.64
1.50
2.9
3.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
116
996
1.39
1.49
14.2
9.4
e9/l
4.0
3.8
0.36
101
869
(3044889) 12 lead EKG panel
136
1201
1.41
1.47
4.2
3.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
31
207
1.59
1.46
2.0
1.8
s
29.0
29.4
0.19
31
198
(3002582) Erythrocytes [#/volume] in Urine
60
463
1.42
1.43
3.1
2.7
e6/l
17.2
39.6
0.98
46
346
(3011397) Hemoglobin [Presence] in Urine by Test strip
50
374
1.45
1.40
5.1
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
130
1144
1.39
1.40
5.1
3.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
27
177
1.61
1.38
1.6
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
89
741
1.36
1.34
3.2
2.3
nmol/l
77.3
77.3
0.01
84
677
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
107
1.75
1.31
1.2
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
12
62
2.00
1.30
1.2
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
18
2.82
1.29
1.6
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
18
2.82
1.29
1.6
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
18
2.82
1.29
1.6
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
77
1.88
1.29
1.7
1.7
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
7
145
0.46
1.26
1.4
2.7
u/ml
19.7
54.8
—
7
138
(3014051) Protein [Presence] in Urine by Test strip
8
37
2.21
1.23
1.9
1.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
19
2.67
1.22
1.6
1.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
19
2.67
1.22
1.6
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
19
2.67
1.22
1.6
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
8
38
2.15
1.20
6.5
4.6
mg/l
28.6
198.2
—
8
32
(3042936) Bacteria identified in Isolate by Culture
31
218
1.50
1.18
2.0
2.0
—
—
—
0
0
(3015736) pH of Urine
78
647
1.34
1.17
4.4
3.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
20
2.54
1.16
1.4
1.5
u/ml
3.8
2.8
—
5
20
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
50
388
1.38
1.14
3.6
2.6
ng/l
803.1
665.0
0.17
45
319
(3044290) Cell count panel - Cerebral spinal fluid
7
31
2.30
1.11
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
74
1.81
1.09
8.2
8.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
102
886
1.31
1.09
7.3
5.8
e9/l
0.2
0.2
0.50
88
783
(3030467) Casts [#/volume] in Urine by Automated count
53
419
1.36
1.08
3.3
2.7
e6/l
0.2
0.5
0.62
38
306
(3020891) Body temperature
10
53
1.93
1.03
9.2
4.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
134
0.51
1.03
1.4
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
68
564
1.31
1.00
3.8
3.2
e6/l
100.6
61.4
0.21
51
379
(3000330) Specific gravity of Urine by Test strip
12
69
1.79
0.99
4.0
3.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
183
1745
1.57
0.99
5.0
4.3
mmol/l
4.8
4.9
0.62
177
1644
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
30
0.00
0.98
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
31
0.00
0.97
0.0
3.2
—
64.4
—
0
31
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
51
1.80
0.96
1.0
1.3
—
42.1
—
0
7
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
27
2.26
0.94
1.3
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
45
355
1.35
0.93
4.9
4.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
52
420
1.32
0.92
3.3
2.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
29
385
0.71
0.91
2.4
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
30
2.03
0.87
1.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
30
2.03
0.87
1.0
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
75
641
1.27
0.87
4.3
3.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
96
847
1.26
0.84
6.4
5.4
e9/l
0.6
0.5
0.17
80
734
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
26
190
1.42
0.84
2.9
2.3
%
22.1
23.8
0.24
19
159
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
211
0.64
0.84
16.9
5.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
18
122
1.52
0.83
10.2
6.5
mmol/l
1.1
1.3
0.56
18
117
(3006315) Basophils [#/volume] in Blood
96
849
1.25
0.82
6.4
5.5
e9/l
0.0
0.0
0.00
80
734
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
184
1767
1.52
0.82
5.6
4.8
mmol/l
2.9
2.9
0.02
177
1651
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
177
1689
1.42
0.81
4.9
4.3
mmol/l
5.8
5.8
0.02
171
1574
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
33
1.84
0.79
1.3
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
25
0.00
0.79
0.0
1.7
—
—
—
0
0
(4035726)
10
161
0.60
0.79
1.2
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
181
1737
1.44
0.76
4.7
4.3
mmol/l
1.5
1.6
1.98
173
1628
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
181
1737
1.44
0.76
15.0
11.5
mg/l
22.3
19.7
0.38
136
1325
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
24
2.11
0.75
1.0
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
143
1331
1.26
0.74
8.1
7.0
u/l
76.9
76.9
0.00
136
1261
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
7
38
1.87
0.74
7.1
4.6
mg/l
27.7
26.5
—
7
32
(40761536) Microorganisms panel - Urine sediment
18
126
1.47
0.73
3.2
3.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
5
25
2.02
0.73
1.4
1.9
umol/l
27.4
31.8
—
5
18
(3001019) Free T4 and TSH panel - Serum or Plasma
10
157
0.62
0.72
1.3
1.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
38
306
1.30
0.69
2.0
2.3
e6/l
5.1
7.7
0.43
32
272
(3019198) Lymphocytes [#/volume] in Blood
97
871
1.22
0.69
6.5
5.5
e9/l
1.9
2.1
0.47
83
770
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
173
1656
1.33
0.66
6.8
4.9
mu/l
1.8
2.6
0.54
165
1534
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
59
506
1.24
0.65
1.7
1.7
mmol/l
1.6
1.4
0.67
52
440
(3000492) Spirometry study
21
156
1.39
0.64
1.5
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
55
469
1.24
0.63
3.3
3.0
mmol/l
6.7
7.2
0.47
48
392
(3006504) Eosinophils/100 leukocytes in Blood
88
791
1.20
0.60
7.0
5.3
%
3.2
2.8
0.75
83
743
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
49
415
1.24
0.60
2.3
2.4
umol/l
318.6
7690.8
2.51
38
364
(3029937) Albumin [Presence] in Urine by Test strip
51
435
1.23
0.59
4.5
3.5
estimate
0.0
0.0
0.00
19
154
(3000991) Gas panel - Venous blood
16
115
1.43
0.58
11.6
8.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
20
150
1.37
0.58
5.4
4.3
%
18.3
21.1
—
6
68
(3025941) Bacteria identified in Stool by Culture
14
99
1.45
0.56
1.4
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
174
1676
1.29
0.55
4.3
3.8
mmol/l
1.3
1.3
0.74
166
1563
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
9
60
1.52
0.55
1.3
3.0
g/l
1.3
1.5
—
9
51
(3002030) Lymphocytes/100 leukocytes in Blood
90
816
1.19
0.55
6.9
5.4
%
28.5
29.3
0.31
85
767
(3044640) Blood type and Crossmatch panel - Blood
43
503
0.82
0.53
2.5
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
66
1.54
0.53
1.3
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
98
0.60
0.53
1.2
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
166
1593
1.25
0.52
6.0
5.1
mmol/mol
40.0
39.0
0.68
159
1499
(3020564) Creatinine [Moles/volume] in Serum or Plasma
189
1844
1.45
0.52
18.8
13.5
umol/l
71.6
70.3
0.29
189
1844
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
40
1.52
0.52
1.2
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
62
547
1.19
0.51
5.3
5.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
189
0.72
0.51
1.4
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
128
1202
1.18
0.50
2.7
2.9
u/l
44.1
40.3
0.24
121
1138
(3000494) Fungus identified in Specimen by Culture
26
209
1.28
0.49
1.5
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
44
377
1.21
0.49
2.4
1.6
mg/l
1.1
0.8
0.56
34
302
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
47
1.51
0.48
1.0
1.0
—
3.2
—
0
8
(3032080) INR in Blood by Coagulation assay
63
560
1.18
0.48
5.0
5.9
inr
1.1
1.1
0.13
14
171
(36660697) Celiac disease serology panel - Serum
18
140
1.31
0.43
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
31
1.63
0.43
1.0
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
51
575
0.85
0.43
5.6
3.1
ng/l
25.1
22.1
0.13
28
349
(40768443) Skin Pathology biopsy report
10
70
1.45
0.42
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
58
1.39
0.42
1.3
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
58
1.39
0.42
1.0
1.3
—
2.9
—
0
9
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
47
412
1.18
0.42
1.3
1.3
u/ml
0.9
2.1
—
9
132
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
15
0.00
0.41
0.0
2.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
34
1.48
0.40
1.6
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
14
106
1.34
0.40
5.4
6.1
mmol/l
9.3
9.4
0.03
14
99
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(4146454)
0
18
0.00
0.40
0.0
3.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
52
462
1.17
0.39
2.8
3.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
35
1.44
0.39
2.0
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
89
1.37
0.39
1.6
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
25
209
1.22
0.36
1.4
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
45
1.34
0.34
2.5
2.1
%
184.0
178.4
—
6
45
(3024731) MCV [Entitic volume]
194
1914
1.45
0.34
25.6
17.8
fl
90.5
91.1
1.47
194
1891
(1761868) Lipid panel - Serum or Plasma
62
676
0.88
0.33
2.6
2.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
21
176
1.22
0.30
1.5
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
56
1.26
0.29
1.4
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
42
376
1.15
0.29
1.5
1.3
g/l
2.2
2.1
0.08
22
243
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
170
1658
1.17
0.29
13.4
10.9
ml/min/173m2
81.8
84.3
1.06
145
1369
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
63
1.28
0.28
1.4
1.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
28
244
1.17
0.27
4.5
2.5
mmol/l
0.8
0.8
0.09
28
232
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
71
760
0.90
0.27
4.1
3.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
47
427
1.13
0.27
1.5
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
31
275
1.15
0.25
3.1
2.3
mosm/kgh2o
523.5
546.0
0.21
26
234
(40768793) Breast Pathology biopsy report
6
83
0.71
0.24
1.3
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
194
1916
1.42
0.24
26.0
17.9
g/l
134.3
134.4
0.05
194
1892
(3035941) MCH [Entitic mass]
194
1915
1.43
0.24
25.6
17.8
pg
29.9
30.3
2.30
194
1892
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.23
2.0
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
38
1.32
0.23
1.2
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
121
1165
1.10
0.23
3.1
3.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
39
1.29
0.23
1.2
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
79
1.28
0.22
1.7
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
40
365
1.12
0.22
5.4
3.4
kg/l
1.0
1.0
—
5
49
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
11
0.00
0.21
0.0
1.7
—
12.5
—
0
11
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
43
1.17
0.21
1.2
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
13
0.00
0.21
0.0
1.1
—
771.2
—
0
8
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
85.6
—
0
8
(3039443) Prostate specific Ag panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
24.9
—
0
13
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
13
0.00
0.21
0.0
1.2
—
934.3
—
0
6
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
25.3
—
0
8
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
108
1.22
0.20
1.4
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.7
—
0.9
—
0
14
(3016879) Cocaine [Presence] in Urine
6
49
1.23
0.20
1.2
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
28
251
1.13
0.20
1.3
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
50
1.21
0.20
1.0
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
50
1.21
0.20
2.0
1.5
u/l
18.8
33.1
—
6
43
(40760892) CBC W Ordered Manual Differential panel - Blood
45
416
1.11
0.20
3.5
4.9
—
—
—
0
0
(3002256) Pathology report gross observation
26
232
1.14
0.20
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
20
175
1.16
0.19
2.1
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
52
1.16
0.19
1.2
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
52
1.16
0.19
1.2
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
52
1.16
0.19
1.2
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
53
1.14
0.19
1.2
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
26
233
1.13
0.19
1.3
2.2
ug/g
88.6
97.3
0.09
21
183
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
58
1.21
0.18
1.3
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
49
457
1.10
0.18
4.3
3.9
mg/mmol
3.9
4.8
0.13
37
260
(42529406) Shigella sp [Presence] in Stool by Culture
7
59
1.19
0.18
1.3
1.1
—
—
—
0
0
(4034850)
7
60
1.17
0.18
2.4
6.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
13
110
1.19
0.17
2.2
2.9
ug/l
0.4
0.7
—
8
71
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
173
0.86
0.17
1.7
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
47
440
1.09
0.16
3.6
3.1
mg/l
32.0
207.2
0.49
39
268
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
159
1.15
0.15
2.2
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
79
1.15
0.15
1.1
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
357
0.91
0.15
1.4
1.3
u/ml
1.4
8.5
2.39
16
147
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
139
0.85
0.14
2.8
3.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
84
1.20
0.14
1.3
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
92
891
1.06
0.12
6.6
5.8
umol/l
11.9
10.1
0.53
85
845
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
15
168
0.88
0.12
1.6
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
13
146
0.88
0.11
2.9
4.3
%
3.0
0.9
—
5
44
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
166
0.90
0.10
1.1
1.2
iu/ml
122.7
194.8
—
5
74
(3022621) pH of Urine by Test strip
12
106
1.14
0.10
2.8
2.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
87
1.16
0.09
14.6
6.0
mmol/l
26.7
25.6
—
10
87
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
1.5
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
65
1.08
0.08
1.4
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
182
1806
1.09
0.07
13.6
10.9
—
—
—
0
0
(1002224) Polysomnography panel
9
88
1.02
0.07
1.1
1.1
—
—
—
0
0
(4010399)
15
138
1.09
0.06
1.5
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
102
0.88
0.06
1.4
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
110
1.10
0.05
1.5
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
367
1.04
0.05
1.4
1.3
iu/ml
12.0
29.5
2.15
12
123
(3028026) IgM [Mass/volume] in Serum or Plasma
12
111
1.09
0.04
1.8
1.4
g/l
1.2
1.2
0.05
12
100
(40768804) Tissue Pathology biopsy report
77
782
0.98
0.03
2.1
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
36
351
1.03
0.02
1.4
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
27
262
1.04
0.02
1.6
1.4
titre
240.0
563.7
—
5
64
(3009542) Hematocrit [Volume Fraction] of Blood
158
1586
0.98
0.00
21.5
13.0
%
39.8
39.8
0.04
130
1231
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
136
1.03
0.00
1.1
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
13
131
0.99
0.00
6.5
3.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
22
219
1.01
0.00
1.0
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
205
0.97
0.00
1.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
42
418
1.01
0.00
1.4
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
17
168
1.01
0.00
10.9
14.1
inr
1.3
1.3
—
6
31
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
94
0.96
0.00
2.1
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
22.3
—
0
7
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
9.8
—
0
7
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
95
0.94
0.00
1.0
1.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
74
0.94
0.00
2.6
1.8
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
32.4
—
0
9
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
9.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
3.4
—
4.7
—
0
5
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
0
5
0.00
0.00
0.0
3.4
—
2.5
—
0
5
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
5
0.00
0.00
0.0
34.0
—
77.8
—
0
5
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
9.1
—
0
8
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
207.5
—
0
8
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: E4_HYPERPRO_ADVERSE – Hyperprolactinaemia, drug-induced
GWS hits: -
This endpoint is excluded (not available in FinRegistry).